A risk assessment study of SARS-CoV-2 propagation in the manufacturing of cellular products

The potential infection of cellular therapies by SARS-CoV-2 present high risks, as the target patients for these treatments are often immunocompromised or have chronic diseases associated with a higher risk of serious illness and death by COVID-19. The multicellular tropism of this virus presents ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Monte, Enric Redondo, O'Neill, David, Abitorabi, Karin M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724788/
https://www.ncbi.nlm.nih.gov/pubmed/36453030
http://dx.doi.org/10.2217/rme-2022-0096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724788/
https://www.ncbi.nlm.nih.gov/pubmed/36453030
http://dx.doi.org/10.2217/rme-2022-0096

Ejemplares similares